New England Capital Financial Advisors LLC Ionis Pharmaceuticals Inc Transaction History

New England Capital Financial Advisors LLC

$193 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 03, 2023	BUY	$37.12 - $46.52 $48,256 - $60,476	1,300 New	1,300 $53 Million

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$533 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$501 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$365 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$309 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$279 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Capital Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Capital Financial Advisors LLC with notifications on news.

Account